logo image

Bicalutamide information from DrugsUpdate  

See Available Brands of Bicalutamide in India

P - Contraindicated in pregnancy
L - Contraindicated in lactation

Bicalutamide is an oral non-steroidal anti-androgen used in the treatment of prostate cancerand hirsutism.It was first launched in 1995 as a combination treatment (with surgical or medical castration) for advanced prostate cancer and subsequently launched as monotherapy for the treatment of earlier stages of the disease.

Pharmacodynamics

Pharmacokinetics

Absorption
Bicalutamide is well-absorbed following oral administration, although the absolute bioavailability is unknown. Co-administration of Bicalutamide with food has no clinically significant effect on rate or extent of absorption.
Distribution
Bicalutamide is highly protein-bound (96%)
Metabolism/Elimination
Bicalutamide undergoes stereospecific metabolism. The S (inactive) isomer is metabolized primarily by glucuronidation. The R (active) isomer also undergoes glucuronidation but is predominantly oxidized to an inactive metabolite followed by glucuronidation. Both the parent and metabolite glucuronides are eliminated in the urine and feces. The S-enantiomer is rapidly cleared relative to the R-enantiomer, with the R-enantiomer accounting for about 99% of total steady-state plasma levels.

Bicalutamide Indications / Bicalutamide Uses

Information Not Available

Bicalutamide Adverse Reactions / Bicalutamide Side Effects

Nausea, vomiting, diarrhoea, asthenia, gynaecomastia, breat tenderness, hot flushes, pruritus, dry skin, alopecia, hirsutism, decreased libido, impotence, weight gain; less commonly hypersensitivity reactions including angioneurotic oedema & urticaria, intestinal lung disease; rarely abdominal pain, CV disorders ( including angina, heart failure7 arrhythmias) depression, dyspepsia, haematuria, cholestasis, jaundice, thrombocytopenia.

Precautions

Information Not Available

Special Precautions

Monitor liver function regularly in hepatically impaired patients on prolonged therapy. Monitoring serum levels of Prostrate Specific Antigen (PSA) may be useful in evaluating the patients's clinical progress.

Other Drug Interactions

Enhances effects of coumarin anticoagulants

Other Interactions

Information Not Available

Dosage

Oral
Palliative treatment of advanced prostatic cancer:
Adult- When use dwith gonoadrelin analogue.
Usual dose: 50 mg once daily. May be started with or atleast three days before starting with gonoadrelin analogue therapy.
Monotherapy or adjuvant therapy to surgery or radiotherapy in locally advanced prostatic cancer:
Adult- 150mg once daily.

Food(before/after)

Information Not Available

List of Contraindications

Bicalutamide and Pregnancy

Contraindicated in pregnancy

Bicalutamide and Lactation

Contraindicated in lactation

Bicalutamide and Children

Information Not Available

Bicalutamide and Geriatic

Information Not Available

Bicalutamide and Other Contraindications

Hypersensitivity

Bicalutamide is contraindicated in any patient who has shown a hypersensitivity reaction to the drug or any of the tablet’s components. Hypersensitivity reactions including angioneurotic edema and urticaria have been reported

Storage

Information Not Available

Lab interference

Information Not Available

© 2011-2020 DrugsUpdate.com. Disclaimer | Site Map

Feedback
  • Companies that own platforms will own the market
  • Trusted and recognized by all Doctors
  • Access to Millions of Visitors instantly.
  • Companies that own platforms will own the market
  • Trusted and recognized by all Doctors
  • Access to Millions of Visitors instantly.